Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models.
Depetter Y, Geurs S, De Vreese R, Goethals S, Vandoorn E, Laevens A, Steenbrugge J, Meyer E, de Tullio P, Bracke M, D'hooghe M, De Wever O.
Depetter Y, et al. Among authors: de vreese r, de wever o, de tullio p.
Int J Cancer. 2019 Aug 1;145(3):735-747. doi: 10.1002/ijc.32169. Epub 2019 Feb 20.
Int J Cancer. 2019.
PMID: 30694564
Free article.